Stock Price Movement and Market Context
On the trading day, Medi Assist Healthcare Services Ltd outperformed its sector by 1.24%, touching an intraday high of Rs.406.60, a 4.14% rise from the previous close. However, the stock’s closing price at Rs.385.15 represents a new 52-week and all-time low, underscoring persistent downward momentum. The stock currently trades above its 5-day moving average but remains below its 20-day, 50-day, 100-day, and 200-day moving averages, indicating a short-term support level amid longer-term weakness.
The broader market environment was mixed. The Sensex opened sharply higher by 3,656.74 points but lost momentum to close down by 1,314.46 points, or 2.87%, at 84,008.74. The index remains 2.56% below its 52-week high of 86,159.02. Mega-cap stocks led the market, while the miscellaneous sector, which includes insurance, gained 2.88% on the day.
Performance Over the Past Year
Medi Assist Healthcare Services Ltd has experienced a challenging 12 months, with its stock price declining by 27.03%, contrasting with the Sensex’s positive return of 8.84% over the same period. The stock’s 52-week high was Rs.594.40, highlighting the extent of the recent decline. This underperformance extends beyond the last year, as the company has lagged the BSE500 index over the past three years, one year, and three months.
Financial Metrics and Valuation Concerns
The company’s financial profile reveals several factors contributing to the current valuation pressures. Interest expenses over the past nine months have surged by 182.12% to Rs.16.73 crores, exerting strain on profitability. The operating profit to interest ratio for the latest quarter stands at a low 5.23 times, indicating tighter coverage of interest obligations.
Profit before tax excluding other income (PBT less OI) for the most recent quarter was Rs.11.19 crores, reflecting a 51.0% decline compared to the previous four-quarter average. Despite this, the company’s return on equity (ROE) remains at a moderate 14.05%, signalling some underlying fundamental strength.
Valuation metrics suggest the stock is trading at a price-to-book value of 5, which is considered expensive relative to its peers’ historical averages. However, the current market price does represent a discount compared to these peer valuations, reflecting investor caution amid the recent financial trends.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Sector and Industry Positioning
Medi Assist Healthcare Services Ltd operates within the insurance industry, a sector that has seen mixed performance amid evolving market conditions. The miscellaneous sector, which includes insurance, recorded a gain of 2.88% on the day, outperforming the broader market’s decline. Despite this, the company’s stock has not mirrored this sector strength, reflecting company-specific valuation and financial challenges.
Mojo Score and Ratings Update
The company’s Mojo Score currently stands at 19.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, an upgrade from the previous Sell rating. This grading reflects the assessment of financial health, valuation, and performance metrics. The market capitalisation grade is 3, indicating a relatively modest market cap compared to larger peers.
Profitability and Returns Analysis
While the stock price has declined significantly, the company’s profits have shown a modest increase of 5% over the past year. This divergence between earnings growth and share price performance suggests that valuation concerns and interest cost pressures have weighed heavily on investor sentiment. The ROE of 14.05% indicates that the company continues to generate reasonable returns on equity, though this has not translated into share price appreciation.
Is Medi Assist Healthcare Services Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Summary of Key Financial Indicators
The company’s interest expense growth of 182.12% over nine months to Rs.16.73 crores is a notable factor impacting net profitability. The operating profit to interest coverage ratio at 5.23 times is the lowest recorded, signalling tighter margins for servicing debt. The decline in PBT less other income by 51.0% in the latest quarter compared to the previous four-quarter average further highlights earnings pressure.
Despite these headwinds, the company maintains a solid ROE of 14.05%, which is a positive indicator of capital efficiency. The valuation at a price-to-book ratio of 5 remains elevated, though the current share price reflects a discount relative to peer averages.
Technical and Moving Average Analysis
From a technical perspective, the stock’s position above the 5-day moving average but below the 20-day, 50-day, 100-day, and 200-day moving averages suggests short-term support with longer-term resistance levels intact. This pattern indicates that while there may be some short-term buying interest, the overall trend remains subdued.
Comparative Market Performance
Over the last year, Medi Assist Healthcare Services Ltd’s stock has underperformed the Sensex by over 35 percentage points, with the index gaining 8.84% while the stock declined 27.03%. This underperformance extends to the BSE500 index over multiple time frames, reflecting broader challenges in maintaining market confidence.
Conclusion
The new 52-week low of Rs.385.15 for Medi Assist Healthcare Services Ltd marks a significant milestone in the stock’s recent performance, reflecting a combination of rising interest expenses, declining quarterly profits, and valuation pressures. While the company retains some fundamental strengths such as a moderate ROE and profit growth, these have not been sufficient to support the share price amid sector and market dynamics. The stock’s technical indicators and relative performance suggest continued caution in the near term.
Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →
